ID   OCUP-A1
AC   CVCL_CW20
SY   Osaka City University Pancreas-A1
DR   cancercelllines; CVCL_CW20
DR   Cosmic; 2795399
DR   Wikidata; Q54931843
RX   PubMed=27067801;
CC   Population: Japanese.
CC   Doubling time: 20.6 +- 1.2 hours (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=27067801).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (PubMed=27067801).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5722; Pancreatic undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-70Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
RX   PubMed=27067801; DOI=10.1186/s12885-016-2297-y; PMCID=PMC4828819;
RA   Miura K., Kimura K., Amano R., Yamazoe S., Ohira G., Murata A.,
RA   Nishio K., Hasegawa T., Yashiro M., Nakata B., Ohira M., Hirakawa K.;
RT   "Establishment and characterization of new cell lines of anaplastic
RT   pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.";
RL   BMC Cancer 16:268.1-268.13(2016).
//